SALT LAKE CITY, Feb. 23 /PRNewswire-FirstCall/ -- On July 25, 2006, Utah Medical Products, Inc. received a Nasdaq Staff Deficiency Letter. The NASDAQ letter followed the resignation of Dr. Stephen W. Bennett from the board of directors on July 11, 2006.
On February 22, 2007 UTMD announced that its board of directors had elected Dr. James H. Beeson to fill the vacancy on its board of directors for the unexpired term of Dr. Stephen W. Bennett, and serve as a member of the audit committee as one of three independent directors on the board.
Today UTMD received a letter from the Nasdaq confirming, “Staff has determined that the Company [UTMD] complies with the Rule [Marketplace Rules 4350(c) and 4350(d)(2)] and this matter is now closed.”
UTMD expects that Nasdaq and all other financial reporting agencies will now remove the “non-compliance indication” which has been attached to its stock symbol since July 2006.
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures, assembles and markets a broad range of disposable and reusable specialty medical devices designed for better health outcomes for patients and their care-providers. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.
Utah Medical Products, Inc.
CONTACT: Paul Richins of Utah Medical Products, Inc., +1-801-566-1200
Web site: http://www.utahmed.com/
